ACCOUNTS - Final Accounts


Caseware UK (AP4) 2020.0.247 2020.0.247 2020-07-312020-07-312019-08-01falseTherapy services66truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 07510199 2019-08-01 2020-07-31 07510199 2018-08-01 2019-07-31 07510199 2020-07-31 07510199 2019-07-31 07510199 c:Director1 2019-08-01 2020-07-31 07510199 d:OfficeEquipment 2019-08-01 2020-07-31 07510199 d:ComputerEquipment 2019-08-01 2020-07-31 07510199 d:OtherPropertyPlantEquipment 2019-08-01 2020-07-31 07510199 d:OtherPropertyPlantEquipment 2020-07-31 07510199 d:OtherPropertyPlantEquipment 2019-07-31 07510199 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2019-08-01 2020-07-31 07510199 d:Goodwill 2020-07-31 07510199 d:Goodwill 2019-07-31 07510199 d:CurrentFinancialInstruments 2020-07-31 07510199 d:CurrentFinancialInstruments 2019-07-31 07510199 d:CurrentFinancialInstruments d:WithinOneYear 2020-07-31 07510199 d:CurrentFinancialInstruments d:WithinOneYear 2019-07-31 07510199 d:ShareCapital 2020-07-31 07510199 d:ShareCapital 2019-07-31 07510199 d:RetainedEarningsAccumulatedLosses 2020-07-31 07510199 d:RetainedEarningsAccumulatedLosses 2019-07-31 07510199 c:FRS102 2019-08-01 2020-07-31 07510199 c:AuditExempt-NoAccountantsReport 2019-08-01 2020-07-31 07510199 c:FullAccounts 2019-08-01 2020-07-31 07510199 c:PrivateLimitedCompanyLtd 2019-08-01 2020-07-31 07510199 2 2019-08-01 2020-07-31 iso4217:GBP xbrli:pure

Registered number: 07510199









JULIA TERTERYAN THERAPY LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 JULY 2020

 
JULIA TERTERYAN THERAPY LIMITED
REGISTERED NUMBER: 07510199

BALANCE SHEET
AS AT 31 JULY 2020

2020
2019
Note
£
£

Fixed assets
  

Tangible assets
 5 
3,335
2,121

  
3,335
2,121

Current assets
  

Debtors: amounts falling due within one year
 6 
26,787
29,050

Cash at bank and in hand
 7 
18,815
7,864

  
45,602
36,914

Creditors: amounts falling due within one year
 8 
(48,022)
(30,453)

Net current (liabilities)/assets
  
 
 
(2,420)
 
 
6,461

Total assets less current liabilities
  
915
8,582

Provisions for liabilities
  

Deferred tax
  
(441)
(150)

  
 
 
(441)
 
 
(150)

Net assets
  
474
8,432


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
374
8,332

  
474
8,432


Page 1

 
JULIA TERTERYAN THERAPY LIMITED
REGISTERED NUMBER: 07510199
    
BALANCE SHEET (CONTINUED)
AS AT 31 JULY 2020

The Director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The Director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 

J Terteryan
Director

Date: 4 February 2021

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
JULIA TERTERYAN THERAPY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2020

1.


General information

Julia Terteryan Therapy Limited is a Company limited by shares and incorporated in England & Wales under the Companies Act 2006. The address of the registered office is given on the Compnay information page. The nature of the Company's operations and its principal activities are set out in the Directors’ report.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The COVID-19 (coronavirus) pandemic has had an increasingly significant effect on individuals, businesses and organisations worldwide, including Julia Terteryan Therapy Ltd. The outbreak came into widespread public knowledge in 2020. The Directors have taken all necessary measures to satisfy themselves that the Company will continue to be able to operate throughout the current lockdown conditions and beyond. Therefore, the Company is considered to be a going concern and no adjustments have been made to the figures in these financial statements.
The Directors have considered the effect on the value of the assets and liabilities of the Company since the balance sheet date, as well as actual and expected future income and expenditure, cash flow requirements and the Company’s ability to continue as a going concern. They have taken steps to protect the workforce and the business, including its cash flow, so as to be able to maintain liquidity given that the effects of the current crisis are likely to last for several months. 

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
JULIA TERTERYAN THERAPY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2020

2.Accounting policies (continued)

 
2.4

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Profit and loss account in the same period as the related expenditure.

 
2.5

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.8

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 4

 
JULIA TERTERYAN THERAPY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2020

2.Accounting policies (continued)


2.9
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
20% Straightline
Computer equipment
-
20% Straightline

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.10

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.12

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.13

Provisions for liabilities

Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the Balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance sheet.

Page 5

 
JULIA TERTERYAN THERAPY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2020

2.Accounting policies (continued)

 
2.14

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

 
2.15

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 6 (2019 - 6).


4.


Intangible assets




Goodwill

£



Cost


At 1 August 2019
10,500



At 31 July 2020

10,500



Amortisation


At 1 August 2019
10,500



At 31 July 2020

10,500



Net book value



At 31 July 2020
-



At 31 July 2019
-



Page 6

 
JULIA TERTERYAN THERAPY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2020

5.


Tangible fixed assets





Plant and machinery etc

£



Cost or valuation


At 1 August 2019
6,798


Additions
2,018



At 31 July 2020

8,816



Depreciation


At 1 August 2019
4,676


Charge for the year on owned assets
805



At 31 July 2020

5,481



Net book value



At 31 July 2020
3,335



At 31 July 2019
2,121


6.


Debtors

2020
2019
£
£


Trade debtors
6,409
15,433

Other debtors
19,508
-

Prepayments and accrued income
870
13,617

26,787
29,050


Included within other debtors due within one year is a loan to a Director, amounting to £9,754 (2019 - £0). This is repayable on demand and no interest has been charged. 



Page 7

 
JULIA TERTERYAN THERAPY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2020

7.


Cash and cash equivalents

2020
2019
£
£

Cash at bank and in hand
18,815
7,864

18,815
7,864



8.


Creditors: Amounts falling due within one year

2020
2019
£
£

Corporation tax
30,154
20,531

Other taxation and social security
11,135
552

Other creditors
2,397
3,412

Accruals and deferred income
4,336
5,958

48,022
30,453



9.


Related party transactions

Included within other creditors is a loan to the Director totalling £0 (2019: £6). This is repayable on demand and no interest has been charged. 

 
Page 8